Cost-effectiveness studies conducted alongside interventions aimed at improving mental health are often limited in scope because the original study omitted to include a utility measure.
Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D Garry R. Barton, Jo Hodgekins, Miranda Mugford, Peter B. Jones, Tim Croudace and David Fowler Background The UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ-5D; however, this is often not implemented in the area of mental health.
Aims
To assess the appropriateness of using the EQ-5D to measure improvements in mental health.
Method
Seventy-seven participants with psychosis were rated according to the EQ-5D and seven measures of mental health at both pre-and post-intervention. To assess construct validity we compared the (pre-intervention) mean EQ-5D scores for those with milder and more severe scores, according to each of the seven measures. To assess
The BAI assesses the extent to which an individual is bothered by a particular symptom 18 and the BDI assesses the intensity of a particular depressive symptom. 19 Both the BAI and BDI consist of 21 items which are scored on a 0-3 scale, where a higher score denotes more severe symptoms. The BHS consists of 20 items and is designed to assess the degree to which an individual holds negative perceptions about the future. 20 A true or false response format is used and a higher score denotes more negative perceptions. The PANSS assesses the levels of positive, negative and cognitive symptoms that are associated with psychosis, 17 where 30 items are scored on a 1 (absent) to 7 (extreme) scale and a higher score reflects a greater psychopathology. The QLS is designed to assess the functional impairments associated with psychosis, 22 where 21 items are assessed on a 0-6 scale and high scores reflect normal or unimpaired function. The GAF assesses symptom level and psychological, social and occupational functioning, 21 and the SOFAS measures social and occupational functioning. 23 Both measures are assessed on a 1-100 rating scale that is divided into ten deciles, each of which provides a description of functioning and symptom level. A lower score on both the GAF and SOFAS denotes a worse response.
The EQ-5D was developed by the EuroQol group (a consortium of researchers from Western Europe) in the 1990s and was informed by a survey of lay people's concepts of health, and a review of existing instruments. 24 There are five questions, where the respondent is asked to report the level of problems they have (no problems, some/moderate problems, and severe/extreme problems) with regard to mobility, self-care, usual activities, pain, and anxiety/depression. 25 Responses to these five dimensions are also converted into one of 243 different EQ-5D health state descriptions, which range between no problems on all five dimensions (11111) and severe/extreme problems on all five dimensions (33333). We assigned a utility score to each of these 243 health states using the York A1 tariff, 26 giving a measure of health status which ranges between -0.594 and 1 (full health), and where death is equal to zero. This tariff was based on the preferences elicited from a survey of 3395 members of the UK population who used the time trade-off technique to value a number of potential EQ-5D states (the time trade-off seeks to establish how much one would be willing to reduce one's life expectancy by in order to obtain full health). 24 It should thereby be noted that very few of those who valued the EQ-5D states will actually have experienced severe mental illness. The potential importance of this is highlighted by the fact that members of the public tend to estimate the loss in utility associated with particular health states to be higher than that reported by individuals who have actually experienced the health states in question. 27 However, the argument for using valuations based on the general public is that, in a publicly funded system, the views of the general public are most relevant. 28 
Analyses

Overview
Although NICE stated that the EQ-5D was its preferred measure to be used in cost-effectiveness analyses, it did note that the EQ-5D may not be appropriate in all circumstances. 15 Providing evidence of the latter is however not straight forward given that there is much conceptual and methodological difficulty associated with the decision as to whether a measure is 'appropriate', 29 and myriad of differently defined terms have been used within such assessments. 30 That said, Fitzpatrick et al 31 outlined a number of criteria on which evidence should be provided in order to select an appropriate outcome measure. Similarly, Brazier et al 32 developed a checklist for judging the merits of preference-based measures of health such as the EQ-5D. Informed by these papers, and the fact that very few papers have assessed utility measures with regard to such criteria, 33 we measured the performance of the EQ-5D with regard to the criteria of construct validity, convergent validity and responsiveness.
Validity
Validity was assessed in terms of both construct and convergent validity. Construct validity relates to whether a measure can discriminate between two patient groups, one which has a certain trait, and the other which does not. 30 Thus, we sought to assess whether participants in the ISREP trial, who had what might be considered milder scores (at baseline) according to each of the seven mental health measures, had different EQ-5D scores to those who might be considered to have more severe scores. For each of the seven mental health measures, participants were thereby categorised into two groups using the following methods.
On the BAI it has been recommend that scores of 0-9 points be interpreted as normal anxiety, 10-18 as mild-moderate, 19-29 as moderate-severe, and 30-63 as severe anxiety. 18 Thus, we developed two groups -those who had BAI scores 418 and those who had BAI scores 519. On the BDI it has been recommended that scores of 0-13 correspond to minimal depression, 14-19 as mild depression, 20-28 as moderate depression, and 29-63 as severe depression. 34 Accordingly, two groups of participants were created -BDI scores 419 and BDI scores 520. On the BHS a score of 0-3 can be considered minimal, 4-8 as mild, 9-14 as moderate, and 15-20 as severe. 20 Therefore, we compared those with a BHS score 48 with those who had a score 59. On the GAF, a score in the range 51-60 is said to denote moderate symptoms or moderate difficulty in functioning, whereas a score of 61-70 denotes some mild symptoms or some difficulty in functioning. 23 Similarly, on the SOFAS, a score of 51-60 is said to denote moderate difficulty in functioning, whereas a score of 61-70 denotes some difficulty in functioning. 23 Accordingly, for both the GAF and SOFAS, those with scores 460 were compared with those with scores 561. For the remaining two measures we were unable to identify a range on the respective total scores that could be considered to denote mild symptoms (on the PANSS) or a mild level of functional impairment (on the QLS). Consequently, for these two measures, in an attempt to compare those who had milder scores with those who had more severe scores, we simply split the sample into approximately two equal sized groups and compared those who had higher scores with those who had lower scores. Finally, where the aforementioned splits (for either the BAI, BDI, BHS, SOFAS or GAF) resulted in particularly unequal numbers in the milder/more severe groups, the same analysis was also performed using a different split that resulted in approximately equal numbers in each of the two groups.
In order to compare the mean EQ-5D score for participants in each of the above mild/more severe groups, using baseline scores, we conducted the t-test to assess whether the EQ-5D could discriminate between the two groups of participants (who had different scores according to each of the seven measures of mental health). However, as the t-test requires the data to be approximately normally distributed (this was assessed using the Kolmogorov-Smirnov Z-test) and it has been shown that responses to the EQ-5D do not tend to be normally distributed, 35 we also compared the EQ-5D scores for both the mild/more severe groups using the Mann-Whitney U-test. Both the t-test and U-test were conducted in order to assess the hypothesis that non-parametric and parametric methods produce similar results and that the latter are thereby robust to the violation of the normality assumption that health-related quality-of-life data are likely to cause. 36 Finally, it should be noted that more complex regression approaches were considered superfluous as, in contrast to other studies, for example Hurst et al 13 who recruited consecutive out-patients, the strict entry criteria to this study reduced the need to adjust for other factors which might differ between the two groups of participants.
We also assessed whether the mean difference between the EQ-5D scores, at baseline, in different groups could be considered to constitute a minimally important difference (MID). The MID is considered to be the smallest change in score that would necessitate a change in a person's management. 37 Previously the MID has, for example, been estimated by calculating the mean change in the EQ-5D score for those who reported that their general health was either somewhat better than a year ago, or somewhat worse than a year ago, in response to question two of the Short Form-36 (SF-36). 37 Here, in line with the assumption made in a previous paper 38 that considered estimates of the MID which were reported in a number of studies, we assumed that a difference of 40.03 constituted a MID on the EQ-5D.
Finally, as previously undertaken by Kind et al, 39 in an attempt to explain the different EQ-5D scores we also estimated the proportion of participants who reported that they had a problem on each of the five dimensions of the EQ-5D. Here the chisquared test was also conducted in order to assess whether the proportion of participants reporting a particular problem also differed between those with milder scores and those with more severe scores. Convergent validity is determined by how closely a measure is related to other measures of the same construct. 30 Thus, we used the Spearman rank test to assess whether (baseline) scores on the EQ-5D were correlated with the scores on each of the seven measures of mental health in the direction that one would expect.
Responsiveness
Responsiveness has been defined as the ability of a scale to detect changes. 40 In order to assess this criterion, we estimated the mean change in the EQ-5D score (between baseline and follow-up) for those whose scores improved post-intervention, according to each of the seven mental health measures, and compared it with the mean change for those whose scores did not improve (i.e. those whose score worsened or remained the same post-intervention). This definition of responsiveness was chosen in preference to others (see e.g. Terwee et al 14 ) as it is in line with the argument made by Claxton 41 -that decisions (with regard to cost-effectiveness) should be made on the basis of mean values, irrespective of whether such differences are considered for example clinically important or statistically significant. Nevertheless, for the reasons outlined previously, to assess the significance of any differences between these two groups we again conducted the t-test and the U-test. Additionally, the mean difference between these two groups was assessed in relation to the assumed EQ-5D MID of 0.03. Finally, the change in the proportion of participants who reported having no problems (post-intervention compared with pre-intervention on each of the five dimensions of the EQ-5D) was calculated for both those who improved and did not improve post-intervention according to each of the seven measures of mental health.
Results
Participants
Within the two secondary health centres in question between January 2005 and July 2006 a total of 200 participants were identified as meeting the aforementioned inclusion criteria. Of these, 88 gave consent to take part in the study, although a further 11 of these dropped out during the baseline assessment (5 became symptomatic, 5 stated that they were no longer interested, and 1 for personal reasons). Thus, 77 participants were recruited into the study, 55 (71.4%) of whom were male, 50 (64.9%) of whom had a diagnosis of non-affective psychosis, and the average age was 28.9 years (range 18-52). The average duration of illness and the average length of unemployment were 4.8 years and 209 weeks respectively.
At baseline, the EQ-5D was completed by 68 participants (88.3%), where the mean score was 0.676 (95% CI 0.604-0.748) compared with 0.743 (95% CI 0.671-0.816) at 9 months, giving a mean change of 0.043 (95% CI 700.034 to 0.122) (see Table  1 where the mean scores for the BAI, BDI, BHS, PANSS, QLS, GAF and SOFAS are also summarised). Across the five dimensions the proportion who reported a problem on each of the dimensions of the EQ-5D was 26.5% (mobility), 22.1% (self-care), 51.5% (usual activities), 39.7% (pain/discomfort) and 70.6% (anxiety/depression) at baseline (n = 68), compared with 18.8%, 12.5%, 43.8%, 31.3% and 66.7% respectively, at 9 months post-intervention (n = 48).
Analyses
Construct validity
The two groups of participants that were created according to scores on each of the seven measures of mental health had approximately equal numbers, with the exception of the SOFAS. Thus, as well as comparing the EQ-5D scores for those with a SOFAS score of 561 (n = 7) with those with a score 460 (n = 61), we also compared the EQ-5D scores for those with a SOFAS score 551 (n = 25) with those with a score 450 Table 1 Mean scores at both baseline and 9 months post-intervention, and the change in score for each of the seven measures of mental health and the EQ-5D
Baseline score, mean (n) 9-month score, mean (n) Change, mean (n) (n = 43) (a score of 41-50 on the SOFAS denotes serious impairment in social, occupational or school functioning). 23 For each of the seven measures of mental health (including both SOFAS categorisations), those with milder scores were found to have higher mean scores according to the EQ-5D compared with those with more severe scores (Table 2) . However, according to the Kolmogorov-Smirnov Z-test (z = 1.964, P50.001, n = 68), one would reject the null hypothesis that the EQ-5D data were normally distributed. Thus, the significance levels according to the t-test, with regard to the mean difference in utility between those with milder/more severe scores, should be treated with caution, although they are near identical to the significance levels according to the U-test (Table 2 ). Additionally, it should be noted that the mean difference exceeded the assumed MID of 0.03 for all seven measures (range 0.044-0.301). Similar results were also achieved on each of the five dimensions of the EQ-5D. In Table 3 it can be seen that the proportion of participants who reported having problems with each of the dimensions of mobility, self-care, usual activities, pain/discomfort and anxiety/depression was lower for those with milder scores compared with those with more severe scores according to at least five of the seven measures of mental health.
In terms of convergent validity the EQ-5D was correlated with each of the seven measures of mental health in the direction that one would expect, i.e. it was negatively correlated with those measures for which a lower score denotes more severe symptoms/functioning (the BAI, BDI, BHS and PANSS) and positively correlated with the QLS, GAF and SOFAS (Table 4 ). However, it should be noted that the level of correlation was not significant for three of the measures (the PANSS, QLS and SOFAS).
Responsiveness
In Table 5 it can be seen that the mean EQ-5D score was higher (post-intervention) for each of the participant groups who improved according to the seven measures of mental health, i.e. when scores on the BAI, BDI, BHS and QLS increased and scores on the PANSS, GAF and SOFAS decreased. However, contrary to expectations, those who did not improve according to the BHS actually achieved a larger increase in the mean EQ-5D score than was the case for the participants who actually had better BHS scores post-intervention (see Discussion for possible explanations). The significance levels associated with these mean differences are also denoted in Table 5 where, according to the Kolmogorov-Smirnov Z-test (z = 0.857, P = 0.455, n = 45), one cannot reject the null hypothesis that the EQ-5D change scores were normally distributed.
As for the individual dimensions of the EQ-5D (Table 6) , it can be seen that of those who improved (post-intervention) according to each of the seven measures of mental health, a greater proportion tended to report having no problems (post-intervention compared with pre-intervention) with regard to each of the dimensions of mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The main exceptions were that at the 9-month assessment (compared with the baseline) more of those who improved according to the PANSS (2.94%: n = 1 more) reported having a problem with regard to usual activities and more of those who improved according to the SOFAS (6.9%: n = 2 more) reported having a problem with regard to anxiety/depression.
Discussion
We have shown that the mean EQ-5D score for those who were considered to have milder scores was higher than that for those who had more severe scores, according to each of the BAI, BDI, BHS, PANSS, QLS, GAF and SOFAS, and that the mean difference was greater than the assumed MID of 0.03 ( Table 2 ). The EQ-5D was also correlated with each of these seven measures of mental health, in that those with better scores on each of these dimensions also tended to have better EQ-5D scores, although the level of correlation was not significant for three of the measures (Table 4) . Additionally, those who improved (postintervention) according to each of the measures of mental health also had higher mean EQ-5D scores at the 9-month assessment compared with the baseline assessment (Table 5) . It can also be seen that those who had milder scores according to each of the seven measures of mental health, also tended to have fewer problems than those with more severe scores across each of the five dimensions of the EQ-5D (Table 3) . Thus, this would suggest that many of the dimensions of the EQ-5D can be sensitive to changes in the level of mental health. Further support for this argument is provided by the fact that a greater proportion of those who improved, according to each of the seven measures of mental health, also tended to report having no problems on each of the five dimensions of the EQ-5D at follow-up compared with baseline (Table 6) .
One seemingly unexpected result was, however, that those who did not improve according to the BHS actually had a higher mean post-intervention EQ-5D score than those who did improve. Looking at the results in Table 6 , it can be seen that (post-intervention), as one might expect, a greater proportion of those who had more negative perceptions about the future also reported having problems with regard to the anxiety/depression dimension of the EQ-5D. However, a greater proportion also reported having no problems and 15 individuals whose perceptions about the future did not improve actually received other benefits (reflected in the mobility, self-care and pain/discomfort dimensions of the EQ-5D) that outweighed the increased levels of anxiety and depression, although we cannot account for why this occurred. In a similar way, the finding that a greater proportion of those who improved according to the SOFAS actually reported having problems with regard to anxiety and depression may not be contrary to expectations as the SOFAS focuses on social and occupational functioning. That said, the finding that the proportion of those who reported having a problem with regard to usual activities increased among those who improved according to the PANSS cannot be fully accounted for. Similarly, the argument that our results are far from conclusive is bolstered by the fact that only four of the seven measures of mental health were significantly correlated with the EQ-5D.
Comparisons with other studies
A number of previous cost-effectiveness studies in the area of mental health have included the EQ-5D as a measure of benefit, for example Byford et al, 12 Palmer et al, 42 Byford et al 43 and Hakkaart-van Roijen et al. 44 However, in each of these studies, 12, [42] [43] [44] according to the EQ-5D, the intervention was estimated to be no more effective than the comparator with which it was compared (this was often termed 'treatment as usual'). Such results could arise because there was an improvement associated with the intervention, but the EQ-5D may have been insensitive to that improvement, as was pointed out by Byford et al. 12 Alternatively, it could be that any benefits do not constitute sufficient value, according to the EQ-5D, in order for them to increase a person's level of utility. Within this study we have tried to inform this debate by considering the validity and responsiveness of the EQ-5D in a group of people with psychosis. Our findings suggest that the EQ-5D can discriminate between those with milder and more severe scores, and that the EQ-5D is generally responsive to improvements in mental health as measured by the BAI, BDI, BHS, PANSS, QLS, GAF and SOFAS. These findings are consistent with others who have found evidence to support the validity and/or responsiveness of the EQ-5D in people with schizophrenic, schizotypal or delusional disorders, 45 in a group of individuals receiving mental health services 46 and in other areas of health. 13, [47] [48] [49] However, this does not necessarily imply that similar results will be realised in other groups with severe mental illness.
Readers should also be aware that, in addition to the EQ-5D, other measures of utility measurement are available, including the Health Utilities Index 50 and the SF-6D 51 (the latter of which is derived from the SF-36). 52 A number of studies have thereby been undertaken to compare the utility scores derived from these Table 6 Change in the proportion who reported having no problems on each of the five dimensions of the EQ-5D (9-month compared with baseline assessment) for those whose scores improved, and did not improve, post-intervention n Mobility % different multi-attribute health status classification systems, where a common finding is that there are small but important differences between the utility scores estimated by each of the measures. 53 This is in accordance with the conclusion of the only paper which we know to have compared the scores provided by two utility measures (the EQ-5D and SF-6D) in the area of mental health. 54 In a group of people with either a major depressive disorder, dysthymic disorder, panic disorder, social phobia, or generalised anxiety, Lamers et al found that those who were less distressed (according to a checklist of 90 psychological symptoms) tended to have higher scores on the EQ-5D (compared with the SF-6D), whereas those who were more distressed tended to have higher scores on the SF-6D. 54 Differing scores such as these are often explained by the fact that different measures use both different health-state descriptions and different valuation techniques. 29 
Limitations
The main limitation of this study is that it is relatively small (based on 77 participants), and no single experiment can unequivocally prove a construct (evidence of validity can only be provided by a series of converging results). 30 Additionally, although the t-test has previously been used to analyse responses to the EQ-5D (e.g. Hurst et al 13 ) there may be some limitations with regard to the statistical analysis due to the fact that the EQ-5D data were not normally distributed (a requirement for the t-test). That said, we demonstrated that the results of the t-test were robust as the qualitative interpretation of these results (in relation to the P50.05 cut-off) was identical to those obtained using the Mann-Whitney U-test. Furthermore, it should also be recognised that we did not collect sufficient data to enable all of the criteria developed by both Fitzpatrick et al 31 and Brazier et al 32 to be fully assessed. Further research is therefore required before one can conclude that it is wholly appropriate to use the EQ-5D to measure the benefits in mental health evaluations. That said, our results suggest that, for this particular intervention (which focused on social recovery), 16 those who improved according to the BAI, BDI, BHS, PANSS, QLS, GAF and SOFAS, also received benefits in most of the five dimensions of the EQ-5D. Therefore, had we only used a measure of mental health to estimate the benefits of social recovery oriented cognitivebehavioural therapy it could have been that the range of benefits associated with the intervention would have been underestimated.
Implications
Our results suggest that the EQ-5D can discriminate between those with milder and more severe scores, and that the EQ-5D is responsive to improvements in mental health as measured by seven measures of mental health. This suggests that the EQ-5D should be considered for use in future cost-effectiveness studies of mental health interventions. However, as not all of the results were in line with expectations, further research as to the appropriateness of using the EQ-5D in such areas is also warranted. The MRC had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
